UBS’s Keryx Biopharmaceuticals KERX Stock Holding History
Bought
Maintained
Sold
Other funds holding KERX
UBS's KERX Position: Q3 2014 in Review
UBS increased its Keryx Biopharmaceuticals (KERX) stake by 24% in Q3 2014, buying an estimated $439K and bringing the position to 150,630 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2886.
UBS first reported a position in KERX in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.01M in Q1 2014. 140 funds tracked by Wall St. Rank hold KERX as of Q3 2014.
- UBS held 150,630 shares of Keryx Biopharmaceuticals worth $2.07M as of Q3 2014.
- UBS bought 28,692 Keryx Biopharmaceuticals shares in Q3 2014, an estimated $439K.
- Keryx Biopharmaceuticals made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2886 holding.
- UBS first reported a position in Keryx Biopharmaceuticals in Q2 2013 and has held it in 6 quarters since.
- UBS's Keryx Biopharmaceuticals position peaked at $3.01M in Q1 2014.
- 140 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.